Notably, diagnostic accuracy varied by disease stage, with early-stage AD outperforming late-stage AD, particularly with MRPS27, SDHA, SLC25A20, and SYNJ2BP demonstrating more consistent performance (Figs. S1, 2). This evidence concerns the gene SYNJ2BP and Alzheimer disease.